This market's growth is driven by increasing awareness of the early detection of chronic diseases, improved clinical decision-making and accuracy through AI, a shortage of healthcare professionals, advancements in AI technology, and rising regulatory approvals for AI-enabled devices. Additionally, the expanding therapeutic applications of AI-enabled devices contribute to market growth.

Market Lifecycle Stage

The AI-enabled medical imaging solutions market is currently in its development phase. Opportunities within this market are being fueled by the increasing adoption of AI and deep learning in imaging systems, technological advancements in imaging devices, and the growing use of AI-enabled medical imaging solutions in emerging markets. Key market trends include numerous collaborations among industry players, the adoption of machine learning and deep learning technologies in medical imaging, the introduction of new products, and the expansion of companies into the global market.

Impact of COVID-19

The COVID-19 pandemic initially shifted the focus of healthcare systems towards managing the crisis, leading to reduced hospital budgets and slower growth for AI applications. However, AI has been increasingly deployed in radiology departments worldwide to combat COVID-19. AI-based tools played a crucial role in diagnosis, prognosis evaluation, pandemic prediction, and drug discovery related to COVID-19, as highlighted in a September 2021 study published in Frontiers titled "Artificial Intelligence for COVID-19: A Systematic Review." This led to a positive impact on the adoption of AI in clinical settings and decision-making processes during the pandemic.

Sample pages of Report: https://www.infiniumglobalresearch.com/form/919?name=Sample

Market Segmentation

By Modality:

• Computed Tomography (CT)
• Magnetic Resonance (MR)
• X-Ray
• Ultrasound
• Mammography
• Multimodality Imaging Systems
• Other Modalities

The CT segment is expected to dominate the global AI-enabled medical imaging solutions market.

By Product:

• Software
• Hardware

The software segment holds the largest share in the global AI-enabled medical imaging solutions market.

By Deployment Model:

• Cloud- and Web-Based Solutions
• On-Premises Solutions

Cloud- and web-based solutions dominate the global market in this category.

By Workflow:

• Image Acquisition
• Image Analysis
• Detection
• Diagnosis and Treatment Decision Support
• Predictive Analysis and Risk Assessment
• Triage
• Reporting and Communication

The image analysis segment is expected to lead the market based on workflow.

By Therapeutic Application:

• Specialty Imaging
• General Imaging

Specialty imaging is anticipated to dominate the global market.

By Region:

• North America: U.S., Canada
• Europe: Germany, France, U.K., Italy, Spain, Switzerland, Sweden, Netherlands, and Rest-of-Europe
• Asia-Pacific: Japan, China, India, Australia and New Zealand, South Korea, Singapore, and Rest-of-Asia-Pacific
• Rest-of-the-World: Israel, Brazil, Mexico, and Rest-of-the-World

North America is the leading region in the global AI-enabled medical imaging solutions market.

Recent Developments in the Global AI-Enabled Medical Imaging Solutions Market

• November 2022: Aidoc received U.S. FDA approval for its CT-based AI solution for diagnosing aortic dissection (AD) and all vessel occlusions (VOs).
• September 2022: Aidoc partnered with Sana Klinikum Lichtenberg, Germany's largest private hospital network, to integrate its AI solution for pulmonary embolism (PE) across all facilities.
• June 2022: Blackford Analysis Limited partnered with Us2.ai to bring advanced echocardiography analysis tools to the Blackford Platform.
• May 2022: Butterfly Network, Inc. partnered with the Medical University of South Carolina to work on transforming patient care, health education, and medical research.
• August 2021: Blackford Analysis Limited partnered with Qlarity Imaging to bring QuantX Diagnostic AI to radiologists via the Blackford Platform.
• September 2021: Aidoc and Subtle Medical partnered to establish end-to-end AI solutions for medical imaging.
• December 2020: Agfa HealthCare launched RUBEE for AI, a product that helps hospitals integrate AI into their imaging networks.
• May 2020: Agfa HealthCare partnered with Northwest Clinics to expand the imaging platform of clinics with RUBEE for AI.
• November 2021: Butterfly Network, Inc. formed a distribution partnership with Abdul Latif Jameel Health to distribute its Butterfly iQ+ ultrasound device across the Middle East, North Africa, Turkey, and India.
• August 2021: Caption Health partnered exclusively with Butterfly Network Inc. to enhance early disease detection and management with AI-based diagnostics.

Report Overview : https://www.infiniumglobalresearch.com/market-reports/global-ai-enabled-imaging-solutions-market

How This Report Adds Value to an Organization

Product/Innovation Strategy: The report provides a comprehensive understanding of the various AI-enabled medical imaging solutions available for hospitals and diagnostic centers. It covers different modalities (CT, MR, X-ray, ultrasound, mammography, multimodality imaging systems, and other modalities), products (software and hardware), deployment models (cloud- and web-based solutions and on-premises solutions), workflows (image acquisition, image analysis, detection, diagnosis and treatment decision support, predictive analysis and risk assessment, triage, and reporting and communication), and therapeutic applications (specialty imaging and general imaging).

Growth/Marketing Strategy: The global AI-enabled medical imaging solutions market has witnessed significant developments, including business expansions, partnerships, collaborations, mergers and acquisitions, product launches, and funding activities. Partnerships, alliances, and business expansions make up the majority of developments in this market, followed by regulatory and legal activities and new product offerings.

Competitive Strategy: Key players in the global AI-enabled medical imaging solutions market are analyzed and profiled, with a detailed product benchmarking based on workflow, modality, and therapeutic application. This helps the reader understand how players compare against each other, presenting a clear market landscape. Additionally, the report provides insights into competitive strategies such as partnerships, agreements, collaborations, product launches and approvals, and funding scenarios, aiding in the identification of untapped revenue opportunities within the market.